In addition, the expression levels of γ-H2AX were significantly increased in NPC cells treated with a combination of O6BG and olaparib compared with those treated with olaplarib alone (Fig. 7e, f). The gene discussed is H2AX; the disease is nasopharyngeal carcinoma.